Top 10 Heal Care Stocks To Invest In 2019

tags:RHHBY,VKTX,FRPH,CFR,RUBI,BOOT,HBHC,CYRN,MRO,VEA,

Gilead Sciences (NASDAQ:GILD) investors are probably breathing a little easier. On Tuesday, the company reported positive results from a late-stage study of its most advanced drug, filgotinib. The win is particularly important because Gilead Sciences needs new drugs targeting blockbuster indications to offset sliding sales for its hepatitis C drugs. Does filgotinib's latest data make this biotech giant a stock worth buying? 

Delivering the goods

Eager to participate in the multibillion-dollar market for autoimmune-disease treatments, Gilead Sciences licensed filgotinib from Galapagos NV (NASDAQ:GLPG) in 2015. 

IMAGE SOURCE: GETTY IMAGES.

An inhibitor that's highly selective for the JAK1 enzyme, which plays a key role in signaling cytokines that control cell growth and immune responses, filgotinib has had its progress watched closely since it delivered positive phase 2 results in rheumatoid arthritis, a multibillion-dollar treatment market.

Top 10 Heal Care Stocks To Invest In 2019: Roche Holding AG (RHHBY)

Advisors' Opinion:

• [By Todd Campbell]

  Its CEO, Paul Friedman, was CEO of Incyte (NASDAQ:INCY) when it developed and won Food and Drug Administration approval of the blockbuster drug Jakafi, and Madrigal's founder, Ruth Taub, is a former Roche Holdings (NASDAQOTH:RHHBY) research and development veteran who in-licensed MGL-3196 from Roche back in 2008 when Madrigal was operating as VIA Pharmaceuticals. She also happens to be married to Friedman.

• [By ]

  Present weakness is mainly due to the news released by partner Roche (OTCQX:RHHBY) on May 10th that the Phase 3 IMblaze370 study failed to meet its primary endpoint in microsatellite stable metastatic colorectal cancer patients. Anti-PD-L1 asset atezolizumab was combined with Exelexis's cobimetinib, but unfortunately, no statistically-significant improvement in overall survival was observed.

• [By ]

  Roche's (OTCQX:RHHBY) cobas EGFR Mutation Test v2 as a companion diagnostic test with AstraZeneca's IRESSA (gefitinib) in first-line non-small cell lung cancer (NSCLC) is now FDA approved to offer patients an alternative for tissue biopsy an non-invasive option via routine blood draw.

Top 10 Heal Care Stocks To Invest In 2019: Viking Therapeutics, Inc.(VKTX)

Advisors' Opinion:

• [By Maxx Chatsko]

  Shares of development-stage biopharma Viking Therapeutics (NASDAQ:VKTX) jumped nearly 15% today because, well, that's become the new normal for the stock lately. Investors have been quick to hand the company a higher market cap since late May following two positive events concerning a high-priority research area of its pipeline. There's a catch, though: Both of those news items have been external developments, not involving the company directly.

• [By George Budwell, Chuck Saletta, and Todd Campbell]

  So, with the biotech space solidly on the comeback trail, we asked three of our Motley Fool contributors which stocks they think are poised to keep churning higher in February and perhaps for the remainder of the year. They suggested Viking Therapeutics (NASDAQ:VKTX), Cambrex (NYSE:CBM), and Sarepta Therapeutics (NASDAQ:SRPT). Here's why.     

• [By Jim Crumly]

  As for individual stocks, FedEx (NYSE:FDX) fell after missing profit forecasts, while Viking Therapeutics (NASDAQ:VKTX) shot higher on successful results in a trial for a liver disease drug. 

• [By Todd Campbell, Keith Speights, and Brian Feroldi]

  Investing in biotech stocks can be risky because clinical trial failures can lead to eye-popping drops in share prices. Nevertheless, the potential to benefit from revolutionary new medicines can make owning biotech stocks in a diversified portfolio smart. If you're hunting for new biotech stocks to buy, these three Motley Fool investors think you should consider Ligand Pharmaceuticals (NASDAQ:LGND), Viking Therapeutics (NASDAQ:VKTX), and Amarin Corporation (NASDAQ:AMRN). Each of these companies has catalysts that could make now a good time to pick up shares.

• [By Cory Renauer]

  Although the agency is primarily concerned with inflammation and scarring, MGL-3196 impressed investors by helping NASH patients lower liver fat content, measured with an MRI, by 37%, compared with a 9% reduction in the placebo group. Shortly after Madrigal's day in the sun, though, Viking Therapeutics (NASDAQ:VKTX) released data for its TRB agonist that showed a liver fat reduction that was much stronger, but we haven't seen any biopsy results from a Viking candidate yet.

• [By Shane Hupp]

  Get a free copy of the Zacks research report on Viking Therapeutics (VKTX)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Heal Care Stocks To Invest In 2019: FRP Holdings, Inc.(FRPH)

Advisors' Opinion:

• [By Ethan Ryder]

  Shanghai Industrial (OTCMKTS:SGHIY) and FRP (NASDAQ:FRPH) are both multi-sector conglomerates companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, dividends, valuation, profitability, institutional ownership, earnings and analyst recommendations.

• [By Motley Fool Transcribers]

  FRP Holdings Inc  (NASDAQ:FRPH)Q4 2018 Earnings Conference CallMarch 07, 2019, 1:00 p.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Joseph Griffin]

  Shanghai Industrial (OTCMKTS:SGHIY) and FRP (NASDAQ:FRPH) are both multi-sector conglomerates companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, dividends, valuation, profitability, institutional ownership, earnings and analyst recommendations.

• [By Shane Hupp]

  FRP (NASDAQ:FRPH) was downgraded by equities researchers at BidaskClub from a “buy” rating to a “hold” rating in a research note issued on Friday.

• [By Max Byerly]

  FRP Holdings Inc (NASDAQ:FRPH) VP John D. Milton, Jr. sold 3,000 shares of the stock in a transaction that occurred on Thursday, June 14th. The stock was sold at an average price of $59.07, for a total value of $177,210.00. Following the transaction, the vice president now owns 632 shares in the company, valued at approximately $37,332.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Top 10 Heal Care Stocks To Invest In 2019: Cullen/Frost Bankers, Inc.(CFR)

Advisors' Opinion:

• [By Joseph Griffin]

  TRADEMARK VIOLATION WARNING: “Cullen Frost Bankers Inc. Boosts Stake in Cullen/Frost Bankers, Inc. (CFR)” was reported by Ticker Report and is owned by of Ticker Report. If you are reading this article on another domain, it was stolen and reposted in violation of United States and international trademark & copyright laws. The correct version of this article can be read at https://www.tickerreport.com/banking-finance/4153655/cullen-frost-bankers-inc-boosts-stake-in-cullen-frost-bankers-inc-cfr.html.

• [By Brian Feroldi]

  Cullen/Frost Bankers (NYSE:CFR), the holding-company parent of the Texas-based regional banking institution Frost Bank, reported its fourth-quarter and full-year results on Thursday.

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Cullen/Frost Bankers (CFR)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Ethan Ryder]

  News articles about Cullen/Frost Bankers (NYSE:CFR) have been trending somewhat positive on Saturday, according to Accern Sentiment Analysis. The research firm ranks the sentiment of news coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Cullen/Frost Bankers earned a news sentiment score of 0.01 on Accern’s scale. Accern also assigned news stories about the bank an impact score of 46.1866283388257 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

• [By Stephan Byrd]

  Media headlines about Cullen/Frost Bankers (NYSE:CFR) have trended somewhat negative recently, Accern Sentiment reports. The research firm identifies positive and negative news coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Cullen/Frost Bankers earned a news sentiment score of -0.02 on Accern’s scale. Accern also gave news headlines about the bank an impact score of 46.2536959953036 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Top 10 Heal Care Stocks To Invest In 2019: The Rubicon Project, Inc.(RUBI)

Advisors' Opinion:

• [By Motley Fool Transcription]

  The Rubicon Project, Inc. (NYSE:RUBI)Q4 2018 Earnings Conference CallFeb. 27, 2019, 4:30 p.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Max Byerly]

  Rubicon Project (NYSE:RUBI) was upgraded by stock analysts at ValuEngine from a “strong sell” rating to a “sell” rating in a research report issued on Wednesday.

• [By Ethan Ryder]

  Rubicon Project (NYSE: RUBI) is one of 44 publicly-traded companies in the “Computer programming, data processing, & other computer related” industry, but how does it weigh in compared to its competitors? We will compare Rubicon Project to related companies based on the strength of its analyst recommendations, valuation, institutional ownership, dividends, profitability, earnings and risk.

• [By Logan Wallace]

  A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Geode Capital Management LLC lifted its position in The Rubicon Project by 33.1% in the 4th quarter. Geode Capital Management LLC now owns 344,352 shares of the software maker’s stock valued at $1,283,000 after acquiring an additional 85,666 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in The Rubicon Project by 1.0% in the 4th quarter. Dimensional Fund Advisors LP now owns 2,569,051 shares of the software maker’s stock valued at $9,583,000 after acquiring an additional 25,922 shares in the last quarter. Cetera Advisor Networks LLC bought a new stake in The Rubicon Project in the 4th quarter valued at $46,000. D. E. Shaw & Co. Inc. lifted its position in The Rubicon Project by 16.3% in the 4th quarter. D. E. Shaw & Co. Inc. now owns 1,241,389 shares of the software maker’s stock valued at $4,630,000 after acquiring an additional 173,881 shares in the last quarter. Finally, Two Sigma Advisers LP lifted its position in The Rubicon Project by 3.6% in the 4th quarter. Two Sigma Advisers LP now owns 456,325 shares of the software maker’s stock valued at $1,702,000 after acquiring an additional 15,700 shares in the last quarter. 55.62% of the stock is currently owned by institutional investors and hedge funds.

  COPYRIGHT VIOLATION WARNING: “The Rubicon Project (RUBI) Trading 7.1% Higher” was first published by Ticker Report and is owned by of Ticker Report. If you are reading this story on another site, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The legal version of this story can be viewed at https://www.tickerreport.com/banking-finance/4219309/the-rubicon-project-rubi-trading-7-1-higher.html.

  About The Rubicon Project (NYSE:RUBI)

Top 10 Heal Care Stocks To Invest In 2019: Boot Barn Holdings, Inc.(BOOT)

Advisors' Opinion:

• [By Lisa Levin]

  Some of the stocks that may grab investor focus today are:

  Wall Street expects Home Depot Inc (NYSE: HD) to report quarterly earnings at $2.06 per share on revenue of $25.22 billion before the opening bell. Home Depot shares fell 0.04 percent to $191.00 in after-hours trading. Switch Inc (NYSE: SWCH) reported weaker-than-expected earnings for its first quarter on Monday. Switch shares dropped 7.18 percent to $14.36 in the after-hours trading session. Analysts are expecting Boot Barn Holdings, Inc. (NYSE: BOOT) to have earned $0.16 per share on revenue of $163.65 million in the latest quarter. Boot Barn will release earnings after the markets close. Boot Barn shares gained 1.4 percent to $21.80 in after-hours trading. Famous Dave’s of America, Inc. (NASDAQ: DAVE) reported upbeat earnings for its first quarter on Monday. Famous Dave’s of America shares gained 7.69 percent to $8.40 in the after-hours trading session. Before the markets open, Eagle Materials Inc (NYSE: EXP) is estimated to report quarterly earnings at $1.08 per share on revenue of $306.04 million. Eagle Materials shares fell 0.09 percent to $105.72 in after-hours trading.

  Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

• [By Lisa Levin]

  Breaking news

  Deere & Company (NYSE: DE) reported weaker-than-expected results for its second quarter. Applied Materials, Inc. (NASDAQ: AMAT) reported stronger-than-expected results for its second quarter, but issued weak sales outlook for the third quarter. Nordstrom, Inc. (NYSE: JWN) reported upbeat results for its first quarter. Comparable-store sales rose 0.6 percent. Boot Barn Holdings Inc (NYSE: BOOT) disclosed a 7.2 million common stock offering.

• [By Max Byerly]

  Frontier Capital Management Co. LLC lowered its position in shares of Boot Barn Holdings Inc (NYSE:BOOT) by 6.0% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,497,355 shares of the company’s stock after selling 158,610 shares during the period. Frontier Capital Management Co. LLC owned approximately 0.09% of Boot Barn worth $51,820,000 as of its most recent SEC filing.

• [By Lisa Levin]

  Boot Barn Holdings, Inc. (NYSE: BOOT) is expected to post quarterly earnings at $0.16 per share on revenue of $163.65 million.

  Acxiom Corporation (NASDAQ: ACXM) is projected to post quarterly earnings at $0.21 per share on revenue of $239.88 million.

• [By Peter Graham]

  Small cap western and work-related footwear/apparel retailer Boot Barn Holdings (NYSE: BOOT) reported fiscal Q3 2018 earnings as the Company was the 4th most shorted stock on the NYSE last September and still has elevated short interest of 37.26% according to Highshortinterest.com. Net sales increased 12.7% to $224.7 million due to an increase of 5.2% in same store sales, the sales contribution from seven new stores opened over the past twelve months and the four stores acquired from Wood's Boots, and sales from the Country Outfitter site that was acquired in February 2017. Net income was $20.1 million versus $10.5 million, cash stood at $19.1 million at the end of the year and total net debt was $182.9 million. For fiscal Q4 ending March 31, 2018, the Company expects:

Top 10 Heal Care Stocks To Invest In 2019: Hancock Holding Company(HBHC)

Advisors' Opinion:

• [By Max Byerly]

  Wells Fargo & Company MN boosted its stake in shares of Hancock Holding (NASDAQ:HBHC) by 9.0% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 1,114,046 shares of the financial services provider’s stock after purchasing an additional 92,265 shares during the period. Wells Fargo & Company MN’s holdings in Hancock were worth $51,970,000 at the end of the most recent quarter.

Top 10 Heal Care Stocks To Invest In 2019: CYREN Ltd.(CYRN)

Advisors' Opinion:

• [By Lisa Levin] Gainers Pacific Biosciences of California, Inc. (NASDAQ: PACB) rose 11.4 percent to $2.93 in pre-market trading. Check-Cap Ltd. (NASDAQ: CHEK) shares rose 6.3 percent to $4.76 in pre-market trading as the company announced the publication of CE Mark multicenter clinical study results on C-Scan® in Gut. Acacia Communications, Inc. (NASDAQ: ACIA) rose 6 percent to $ 35.20 in pre-market trading. Cellect Biotechnology Ltd. (NASDAQ: APOP) rose 6 percent to $7.60 in pre-market trading. Hexindai Inc. (NASDAQ: HX) rose 5.7 percent to $12.70 in pre-market trading. MoSys, Inc. (NASDAQ: MOSY) shares rose 5.3 percent to $2.07 in pre-market trading. Micron Technology, Inc. (NASDAQ: MU) rose 5 percent to $58.20 in pre-market trading after reporting a $10 billion buyback plan. Golden Ocean Group Limited (NASDAQ: GOGL) rose 4.1 percent to $8.63 in pre-market trading. MorphoSys AG (NASDAQ: MOR) rose 3.5 percent to $26.99 in pre-market trading. Cyren Ltd (NASDAQ: CYRN) shares rose 3.4 percent to $2.90 in pre-market trading. after reporting Q1 results. Box, Inc. (NYSE: BOX) rose 3.4 percent to $28.76 in pre-market trading. Kohl's Corporation (NYSE: KSS) shares rose 3.3 percent to $67.60 in the pre-market trading session after the company reported upbeat quarterly earnings. Micro Focus International plc (NYSE: MFGP) shares rose 3.1 percent to $18.40 in pre-market trading.

   

• [By Lisa Levin] Companies Reporting Before The Bell Advance Auto Parts, Inc. (NYSE: AAP) is projected to report quarterly earnings at $1.97 per share on revenue of $2.91 billion. Kohl's Corporation (NYSE: KSS) is expected to report quarterly earnings at $0.5 per share on revenue of $3.95 billion. The TJX Companies, Inc. (NYSE: TJX) is projected to report quarterly earnings at $1.02 per share on revenue of $8.47 billion. AutoZone, Inc. (NYSE: AZO) is estimated to report quarterly earnings at $13.01 per share on revenue of $2.72 billion. Dycom Industries, Inc. (NYSE: DY) is projected to report quarterly earnings at $0.7 per share on revenue of $734.86 million. Eaton Vance Corp. (NYSE: EV) is estimated to report quarterly earnings at $0.79 per share on revenue of $425.42 million. Photronics, Inc. (NASDAQ: PLAB) is expected to report quarterly earnings at $0.07 per share on revenue of $124.17 million. Cracker Barrel Old Country Store, Inc. (NASDAQ: CBRL) is estimated to report quarterly earnings at $1.93 per share on revenue of $715.15 million. Radcom Ltd. (NASDAQ: RDCM) is expected to post quarterly earnings at $1.96 per share on revenue of $718.59 million. Clear Channel Outdoor Holdings, Inc. (NYSE: CCO) is projected to report quarterly earnings at $0.04 per share on revenue of $718.96 million. CYREN Ltd. (NASDAQ: CYRN) is estimated to report quarterly loss at $0.08 per share on revenue of $7.72 million. Ferroglobe PLC (NYSE: GSM) is projected to report quarterly earnings at $0.16 per share on revenue of $559.15 million. Dr. Reddy's Laboratories Limited (NYSE: RDY) is estimated to report earnings for its fourth quarter. BioLineRx Ltd. (NASDAQ: BLRX) is expected to report quarterly loss at $0.07 per share. Toll Brothers, Inc. (NYSE: TOL) is estimated to post quarterly earnings at $0.76 per share on revenue of $1.58 billion.

   

• [By Lisa Levin] Gainers Regional Health Properties, Inc. (NYSE: RHE) shares surged 56 percent to $0.3980. Precipio, Inc. (NASDAQ: PRPO) shares jumped 34 percent to $0.5632 after the nano-cap specialty diagnostics company said it saw an acceleration of sales in its Pathology services in April. The company now expects to see a sequential double digit quarterly sales growth. SenesTech, Inc. (NASDAQ: SNES) rose 16 percent to $1.45 after trading higher at one point Monday by nearly 300 percent. The nano-cap developer of pest control said the California state government approved the company's ContraPest for user in the state. America's Car-Mart, Inc. (NASDAQ: CRMT) gained 13.3 percent to $61.975 after reporting upbeat Q4 results. Check-Cap Ltd. (NASDAQ: CHEK) shares gained 9.8 percent to $4.92 as the company announced the publication of CE Mark multicenter clinical study results on C-Scan® in Gut. Arcimoto, Inc. (NASDAQ: FUV) rose 8.3 percent to $3.41. Ferroglobe PLC (NYSE: GSM) gained 7 percent to $12.13 following stronger-than-expected quarterly earnings. Photronics, Inc. (NASDAQ: PLAB) shares climbed 6.5 percent to $9.00 after the company reported upbeat Q2 results. Micron Technology, Inc. (NASDAQ: MU) rose 6.2 percent to $58.94 after reporting a $10 billion buyback plan. Blink Charging Co. (NASDAQ: BLNK) gained 6.2 percent to $7.53. Blink Charging disclosed that its vehicle charging network exceeds 125,000 members. The Container Store Group, Inc. (NYSE: TCS) gained 5.4 percent to $7.97. Container Store is expected to release quarterly earnings after the closing bell. Cyren Ltd (NASDAQ: CYRN) shares rose 5.4 percent to $2.95 after reporting Q1 results.

  Check out these big penny stock gainers and losers

Top 10 Heal Care Stocks To Invest In 2019: Marathon Oil Corporation(MRO)

Advisors' Opinion:

• [By Matthew DiLallo]

  Marathon Oil (NYSE:MRO) delivered exceptional operational and financial results in 2018. Not only did its U.S. oil production outperform the midpoint of its initial guidance range by 22.5%, but it also generated a boatload of free cash flow. That strong performance is one of many reasons Marathon CEO Lee Tillman believes his company checks all the boxes for investors. He laid out the case for the company on its fourth-quarter conference call, detailing four reasons Marathon is an ideal oil stock. Here's what he said.

• [By Dan Caplinger]

  The stock market largely gained ground on Friday, although triple-digit gains for the Dow Jones Industrial Average were offset somewhat by modest losses in the Nasdaq Composite. European Union tariffs were set to take effect today on more than $3 billion in U.S. goods, representing the latest escalation in trade tensions between the U.S. and trade partners across the globe. Yet investors were ready for a break after several days of poor performance for the overall market, and good news from several companies helped set a positive mood on Wall Street. Marathon Oil (NYSE:MRO), WillScot (NASDAQ: WSC), and Del Taco Restaurants (NASDAQ:TACO) were among the best performers on the day. Here's why they did so well.

• [By Max Byerly]

  Get a free copy of the Zacks research report on Marathon Oil (MRO)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Matthew DiLallo]

  Marathon Oil (NYSE:MRO) based its 2019 plans on oil averaging $50 a barrel. At that price point, the company can fund its $2.6 billion capital spending plan -- enough money to grow its U.S. oil production by 12% this year -- and its dividend with plenty of room to spare. Marathon has so much breathing room that it can fund its 2019 budget as well as its dividend at $45 oil, which means it's on track to produce a gusher of free cash now that oil is in the mid-$50s. Marathon currently expects to return the bulk of that money to shareholders through additional share repurchases, which sets up investors to potentially earn some high-octane total returns this year if oil keeps going higher.

• [By Joseph Griffin]

  Melrose Industries (LON:MRO) issued its earnings results on Thursday. The company reported GBX 5.80 ($0.07) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of GBX 4.40 ($0.06) by GBX 1.40 ($0.02), Digital Look Earnings reports. Melrose Industries had a negative return on equity of 4.75% and a negative net margin of 4.58%.

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Marathon Oil (MRO)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Heal Care Stocks To Invest In 2019: Vanguard FTSE Developed Markets ETF (VEA)

Advisors' Opinion:

• [By Jim Crumly]

  Global stocks retreated on worries about Turkey, sending the Vanguard FTSE Developed Markets ETF (NYSEMKT:VEA) down 1.9%. The materials sector was the weakest among domestic issues; the Materials Select Sector SPDR ETF (NYSEMKT:XLB) fell 1.4%. 

• [By Ethan Ryder]

  RPTC Inc. boosted its position in VANGUARD TAX-MA/FTSE DEVELOPED MKTS (NYSEARCA:VEA) by 1.3% in the 2nd quarter, Holdings Channel reports. The firm owned 114,120 shares of the company’s stock after acquiring an additional 1,423 shares during the period. VANGUARD TAX-MA/FTSE DEVELOPED MKTS makes up about 1.1% of RPTC Inc.’s portfolio, making the stock its 10th largest position. RPTC Inc.’s holdings in VANGUARD TAX-MA/FTSE DEVELOPED MKTS were worth $4,896,000 at the end of the most recent quarter.

• [By Shane Hupp]

  Viva Energy Group Ltd (ASX:VEA) declared a final dividend on Friday, March 1st, MarketIndexAU reports. Shareholders of record on Monday, April 15th will be given a dividend of 0.048 per share on Monday, April 15th. This represents a yield of 1.98%. The ex-dividend date of this dividend is Wednesday, March 27th.

• [By Stephan Byrd]

  ILLEGAL ACTIVITY WARNING: “Steinberg Global Asset Management Sells 11,006 Shares of Vanguard FTSE Developed Markets ETF (VEA)” was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another website, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this report can be accessed at https://www.tickerreport.com/banking-finance/4141323/steinberg-global-asset-management-sells-11006-shares-of-vanguard-ftse-developed-markets-etf-vea.html.